Avalo Therapeutics Inc (AVTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Garry A. Neil
Employees:
40
540 GAITHER ROAD, SUITE 400, ROCKVILLE, MD, 20850
410-522-8707

Avalo Therapeutics, Inc. discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. The company also engages in developing AVTX-007, a fully human Anti-IL-18 monoclonal antibody that is under Phase I clinical trial for the treatment of still's disease and systemic juvenile idiopathic arthritis.

Data derived from most recent annual or quarterly report
Market Cap 36.961 Million Shares Outstanding13.201 Million Avg 30-day Volume 81.409 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.24
Price to Revenue1.3312 Debt to Equity-3.154 EBITDA-24.064 Million
Price to Book Value0.0 Operating Margin-146.25140000000002 Enterprise Value26.117 Million
Current Ratio0.828 EPS Growth-2.343 Quick Ratio0.755
1 Yr BETA 0.2518 52-week High/Low 7.41 / 1.41 Profit Margin-170.3567
Operating Cash Flow Growth69.7915 Altman Z-Score-13.7806 Free Cash Flow to Firm -13.653 Million
Earnings Report2023-08-03

Are you looking for this stock instead?

View SEC Filings from AVTX instead.

View recent insider trading info

Avalo Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AVTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

174.8 Thousand total shares from 23 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CAISSA CAPITAL MANAGEMENT LTD.

  • 10% Owner
 1,568,515 2023-05-31 10

NEIL GARRY ARTHUR CEO AND CHAIRMAN OF THE BOARD

  • Officer
  • Director
 0 2023-05-15 3

SULLIVAN CHRISTOPHER RYAN CHIEF FINANCIAL OFFICER

  • Officer
 0 2023-05-15 2

ALMENOFF JUNE SHERIE

  • Director
 0 2023-03-31 2

PERSSON MAGNUS

  • Director
 0 2023-03-31 2

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • 10% Owner
 8,414,370 2023-02-03 1

KAPLAN GILLA

  • Director
 30,359 2022-03-31 0

MILLER JOSEPH M

  • Director
 20,239 2022-03-31 0

SMOLINSKI STEPHEN CHIEF COMMERCIAL OFFICER

  • Officer
 400,000 2022-01-04 0

HARRELL JAMES ARCHIE JR CHIEF COMMERCIAL OFFICER

  • Officer
 36,766 2021-12-10 0

WILKINS H JEFFREY CHIEF MEDICAL OFFICER

  • Officer
 33,373 2021-12-10 0

GREENWAY SCHOND L. CFO

  • Officer
 3,883 2021-12-10 0

GUTRY PHIL

  • Director
 0 2021-12-01 0

CHAN MITCHELL

  • Director
 0 2021-12-01 0

BRUHN SUZANNE LOUISE

  • Director
 0 2021-11-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-06-02 16:22:32 -0400 2023-05-31 P 844 $2.87 a 1,386,215 indirect

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-30 16:27:36 -0400 2023-05-30 P 671 $2.87 a 1,385,371 indirect -2.439 0.0 1 -2.439 2

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-30 16:27:36 -0400 2023-05-25 P 2,000 $2.77 a 1,384,700 indirect -2.439 0.0 1 -2.439 2

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-24 16:15:01 -0400 2023-05-24 P 5,519 $2.96 a 1,382,700 indirect 14.3396 14.3396 2 0.0 1

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-24 16:15:01 -0400 2023-05-24 P 3,481 $3.01 a 1,377,181 indirect 14.3396 14.3396 2 0.0 1

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-22 16:30:01 -0400 2023-05-22 P 7,000 $3.34 a 1,373,700 indirect -4.6205 -5.2805 0.0 1 -12.5413 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-22 16:30:01 -0400 2023-05-19 P 6,500 $3.52 a 1,366,700 indirect -4.6205 -5.2805 0.0 1 -12.5413 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-22 16:30:01 -0400 2023-05-18 P 13,121 $3.29 a 1,360,200 indirect -4.6205 -5.2805 0.0 1 -12.5413 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-16 17:23:43 -0400 2023-05-16 P 379 $2.75 a 1,347,079 indirect 17.9211 3.5842 21.8638 3 0.0 1

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-16 17:23:43 -0400 2023-05-15 P 1,715 $2.55 a 1,346,700 indirect 17.9211 3.5842 21.8638 3 0.0 1

NEIL GARRY ARTHUR - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2023-05-17 07:43:23 -0400 2023-05-15 A 100,000 a 100,000 direct

SULLIVAN CHRISTOPHER RYAN - Officer CHIEF FINANCIAL OFFICER

2023-05-17 07:44:53 -0400 2023-05-15 A 40,000 a 40,000 direct

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-16 17:23:43 -0400 2023-05-12 P 2,285 $2.45 a 1,344,985 indirect 17.9211 3.5842 21.8638 3 0.0 1

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-08 16:10:27 -0400 2023-05-08 P 5,000 $2.62 a 1,342,700 indirect -4.8263 6.5637 6.5637 6 -7.3359 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-08 16:10:27 -0400 2023-05-05 P 5,000 $2.88 a 1,337,700 indirect -4.8263 6.5637 6.5637 6 -7.3359 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-05-08 16:10:27 -0400 2023-05-04 P 15,000 $2.79 a 1,332,700 indirect -4.8263 6.5637 6.5637 6 -7.3359 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-27 16:07:38 -0400 2023-04-27 P 1,504 $2.96 a 1,317,700 indirect 5.8419 -10.6529 6.5292 3 -10.6529 6

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-27 16:07:38 -0400 2023-04-26 P 425 $2.97 a 1,316,196 indirect 5.8419 -10.6529 6.5292 3 -10.6529 6

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-27 16:07:38 -0400 2023-04-25 P 5,571 $3.00 a 1,315,771 indirect 5.8419 -10.6529 6.5292 3 -10.6529 6

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-24 16:32:46 -0400 2023-04-24 P 12,500 $3.06 a 1,310,200 indirect 1.6835 4.3771 4.3771 6 -5.0505 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-24 16:32:46 -0400 2023-04-20 P 5,000 $3.08 a 1,297,700 indirect 1.6835 4.3771 4.3771 6 -5.0505 3

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-18 16:08:00 -0400 2023-04-18 P 10,000 $2.94 a 1,292,700 indirect 0.8847 2.756 -4.7295 15.6856 23 -18.3396 17

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-18 16:08:00 -0400 2023-04-17 P 15,000 $2.96 a 1,282,700 indirect 0.8847 2.756 -4.7295 15.6856 23 -18.3396 17

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-11 16:51:36 -0400 2023-04-11 P 25,000 $2.84 a 1,267,700 indirect -6.1818 6.8727 5.0909 23.6364 28 -12.7273 22

CAISSA CAPITAL MANAGEMENT LTD. - > 10% Owner see footnote (1)

2023-04-11 16:51:36 -0400 2023-04-10 P 31,329 $2.28 a 1,242,700 indirect -6.1818 6.8727 5.0909 23.6364 28 -12.7273 22

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AVALO THERAPEUTICS INC AVTX 2023-06-02 22:15:04 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 21:45:04 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 21:15:04 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 20:45:03 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 20:15:05 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 19:45:04 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 19:15:04 UTC 1.321 3.739 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 18:45:04 UTC 1.3185 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 18:15:04 UTC 1.3185 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 17:45:03 UTC 1.3185 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 17:15:04 UTC 1.3185 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 16:45:03 UTC 1.3285 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 16:15:04 UTC 1.3285 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 15:45:04 UTC 1.3285 3.7415 95000
AVALO THERAPEUTICS INC AVTX 2023-06-02 15:15:03 UTC 1.3285 3.7415 85000
AVALO THERAPEUTICS INC AVTX 2023-06-02 14:45:04 UTC 1.3285 3.7415 85000
AVALO THERAPEUTICS INC AVTX 2023-06-02 14:15:03 UTC 1.3285 3.7415 85000
AVALO THERAPEUTICS INC AVTX 2023-06-02 13:45:03 UTC 0.4794 4.5906 85000
AVALO THERAPEUTICS INC AVTX 2023-06-02 13:15:04 UTC 0.4794 4.5906 85000
AVALO THERAPEUTICS INC AVTX 2023-06-02 12:45:03 UTC 0.4794 4.5906 85000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments